Mupirocin-Resistant Staphylococcus aureus in Iran: A Biofilm Production and Genetic Characteristics

Table 2

A summary of MDR among samples under study.

Simultaneous resistance to antibiotics	Resistance profile	Resistance pattern^a	Type of samples^b (; % indicated when not 100%)	Number of isolates (%)
Eight	A	PEN, GEN, KAN, AMK, TET, ERY, CLI, CIP	W (6; 40), B (3; 20), A (6; 40)	15 (31.3)
Seven	B	PEN, GEN, TOB, TET, ERY, CIP, SXT	W (7; 70), A (2; 20), U (1; 10)	10 (20.8)
	C	PEN, GEN, KAN, TOB, TET, ERY, CLI	R (1; 20), A (2; 40), U (2; 40)	5 (10.4)
Five	D	PEN, CIP, RIF, SYN, FUS	W (1; 50), B (1; 50)	2 (4.2)
	E	PEN, AMK, ERY, SXT, FUS	B (1)	1 (2.1)
	F	PEN, GEN, CIP, RIF, SYN	W (3; 37.5), U (1; 12.5), B (2; 25), R (2; 25)	8 (16.6)
	G	PEN, GEN, AMK, CIP, RIF	U (1)	1 (2.1)
	H	PEN, KAN, CIP, TET, SYN	U (1)	1 (2.1)
Four	I	PEN, GEN, TET, FUS	B (1)	1 (2.1)
	J	PEN, AMK, ERY, SXT	W (2; 66.7), B (1; 33.3)	3 (6.2)
Without	K	-	W (1)	1 (2.1)

^aAMK: amikacin; CLI: clindamycin; CIP: ciprofloxacin; ERY: erythromycin; FA: fusidic cid; GEN: gentamicin; KAN: kanamycin; PEN: penicillin; RIF: rifampicin; SYN: quinupristin-dalfopristin; SXT: trimethoprim-sulfamethoxazole; TET: tetracycline; TOB: tobramycin. ^bW: wound; B: blood; A: abscess; U: urine; R: respiratory tract secretions.